ESR1 and breast cancer: This was further corroborated by PAM50-based analysis, where we found MCF7 ESR1 mutant cells were predominantly called as basal subtype with above 70% probability (Supplementary Fig. 3a) and exhibited gene expressional similarities to basal breast cancer cell lines (Supplementary Fig. 3b).